Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy

American Journal of Neuroradiology

Volumn 32, Issue 5, 2011, Pages 898-902

  Liu, Z ^a   Zheng, D ^b   Wang, Xiaoying ^a   Zhang, Jue ^b   Xie, S ^a   Xiao, J ^a   Jiang, X ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN INFARCTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; GRAY MATTER; HUMAN; MALE; MELAS SYNDROME; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; SCHOOL CHILD;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN; CHILD; CHOLINE; CREATININE; DIFFUSION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MELAS SYNDROME; NEURONS; YOUNG ADULT;

EID: 79956091500     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A2395     Document Type: Article

References (46)

1. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time dependent field gradient. J Chem Phys 1965;42:288-92
2. Busza AL, Allen KL, King MD, et al. Diffusion-weighted imaging studies of cerebral ischemia in gerbils: potential relevance to energy failure. Stroke 1992;23:1602-12
3. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-45
4. Liu Z, Liu X, Hui L, et al. The appearance of ADCs in the non-affected areas of the patients with MELAS. Neuroradiology 2011;53:227-32
5. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke 1999;30:1591-97 (Pubitemid 29379608)
6. Wick M, Nagatomo Y, Prielmeier F. Alteration of intracellular metabolite diffusion in rat brain in vivo during ischemia and reperfusion. Stroke 1995;26:1930-34
7. Szafer A, Zhong J, Anderson AW, et al. Diffusion-weighted imaging in tissues: theoretical models. NMR Biomed 1995;8:289-96
8. Gujar SK, Maheshwari S, Bjorkman-Burtscher I, et al. Magnetic resonance spectroscopy. J Neuroophthalmol 2005;25:217-26 (Pubitemid 41306683)
9. Hajek M, Dezortova M. Introduction to clinical in vivo MR spectroscopy. Eur J Radiol 2008;67:185-93
10. Posse S, Cuenod CA, Le Bihan D.Humanbrain: proton diffusionMRspectroscopy. Radiology 1993;188:719-25
11. Harada M, Uno M, Hong F, et al. Diffusion-weighted in vivo localized proton MR spectroscopy of human cerebral ischemia and tumor. NMR Biomed 2002;15:69-74 (Pubitemid 34177170)
12. Ellegood J, Hanstock CC, and Beaulieu C. Trace apparent diffusion coefficients of metabolites in human brain using diffusion weighted magnetic resonance spectroscopy. Magn Reson Med 2005;53:1025-32 (Pubitemid 40627777)
13. Ellegood J, Hanstock CC, Beaulieu C. Diffusion tensor spectroscopy (DTS) of human brain. Magn Reson Med 2006;55:1-8 (Pubitemid 43062921)
14. Merboldt KD, Horstermann D, Hanicke W, et al. Molecular self-diffusion of intracellular metabolites in rat brain in vivo investigated by localized proton NMR diffusion spectroscopy. Magn Reson Med 1993;29:125-29 (Pubitemid 23063081)
15. Wick M, Nagatomo Y, Prielmeier F, et al. Alteration of intracellular metabolite diffusion in rat brain in vivo during ischemia and reperfusion. Stroke 1995;26:1930-33
16. Abe O, Okubo T, Hayashi N, et al. Temporal changes of the apparent diffusion coefficients of water and metabolites in rats with hemispheric infarction: experimental study of transhemispheric diaschisis in the contralateral hemisphere at 7 Tesla. J Cereb Blood Flow Metab 2000;20:726-35 (Pubitemid 30217511)
17. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases.NEngl J Med 2003;348:2656-68 (Pubitemid 36741594)
18. Hanna MG, Nelson IP, Morgan-Hughes JA, et al. MELAS: a new disease-associated mitochondrialDNAmutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry 1998;65:512-17 (Pubitemid 28438883)
19. Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002;59:816-24
20. Ohama E, Ohara S, Ikuta F, et al. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226-33 (Pubitemid 17142260)
21. Takahashi N, Shimada T, Murakami Y, et al. Vascular involvement in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Am J Med Sci 2005;329:265-66 (Pubitemid 40695454)
22. Oppenheim C, Galanaud D, Samson Y, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000;69:248-50 (Pubitemid 30466034)
23. Nicolay K, Braun KPJ, de Graaf RA, et al. Diffusion NMR spectroscopy. NMR Biomed 2001;14:94-111 (Pubitemid 32401351)
24. van der Toorn A, Dijkhuizen RM, Tulleken CA, et al. Diffusion of metabolites in normal and ischemic rat brain measured by localized 1H MRS. Magn Reson Med 1996;36:914-22 (Pubitemid 26396819)
25. Haase A, Frahm J, Hanicke W, et al. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985;30:341-44 (Pubitemid 15110036)
26. Dreher W, Busch E, Leibfritz D. Changes in apparent diffusion coefficients of metabolites in rat brain after middle cerebral artery occlusion measured by proton magnetic resonance spectroscopy. Magn Reson Med 2001;45:383-89 (Pubitemid 32173263)
27. Assaf Y, Cohen Y. In vivo and in vitro bi-exponential diffusion of N-acetyl aspartate (NAA) in rat brain: a potential structural probe? NMR Biomed 1998;11:67-74 (Pubitemid 28163097)
28. Moffett JR, Namboodiri MA, Cangro CB, et al. Immunohistochemical localization of N-acetylaspartate in rat brain. Neuroreport 1991;2:131-34
29. Patel TB, Clark JB. Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem J 1979;184:539-46 (Pubitemid 10183588)
30. Arun P, Moffett JR, Namboodiri MA. Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Neurochem Int 2009;55:219-25. Epub 2009 Mar 17
31. Boulanger Y, Labelle M, Khiat A. Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Res Rev 2000;33:380-89
32. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000;80:1107-213 (Pubitemid 30452013)
33. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1-15 (Pubitemid 26024702)
34. Pasantes-Morales H, Tuz K. Volume changes in neurons: hyperexcitability and neuronal death. Contrib Nephrol 2006;152:221-40 (Pubitemid 44672111)
35. Lindroos MM, Borra RJ, Parkkola R, et al. Cerebral oxygen and glucose metabolism in patients with mitochondrial m. 3243A4G mutation. Brain 2009: 132(pt 12);3274-3284
36. Iizuka T, Sakai F, Ide T, et al. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS: implication of neurovascular cellular mechanism. J Neurol Sci 2007;257:126-38 (Pubitemid 46856497)
37. Yonemura K, Hasegawa Y, Kimura K, et al. Diffusion-weighted MR imaging in a case of mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. AJNR Am J Neuroradiol 2001;22:269-72 (Pubitemid 32163454)
38. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995;16:233-39
39. Ducreux D, Nasser G, Lacroix C, et al. MR diffusion tensor imaging, fiber tracking, and single-voxel spectroscopy findings in an unusual MELAS case. AJNR Am J Neuroradiol 2005;26:1840-44 (Pubitemid 43853689)
40. Katayama Y, Maeda K, Iizuka T. Accumulation of oxidative stress around the stroke-like lesions of MELAS patients. Mitochondrion 2009;9:306-13. Epub 2009 Apr 23
41. Gilchrist JM, Sikirica M, Stopa E, et al. Adult-onset MELAS evidence for involvement of neurons as well as cerebral vasculature in strokelike episodes. Stroke 1996;27:1420-23 (Pubitemid 26286179)
42. Betts J, Jaros E, Perry RH, et al. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropathol Appl Neurobiol 2006;32:359-73 (Pubitemid 44015578)
43. Tanahashi C, Nakayama A, Yoshida M, et al. MELAS with the mitochondrial DNA 3243 point mutation: a neuropathological study. Acta Neuropathol 2000;99:31-38 (Pubitemid 30093436)
44. Mizukami K, Sasaki M, Suzuki T, et al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol 1992;83:449-52
45. Burgoyne LA. The mechanisms of pyknosis: hypercondensation and death. Exp Cell Res 1999;248:214-22 (Pubitemid 29393944)
46. Liess C, Radda GK, Clarke K. Metabolite and water apparent diffusion coefficients in the isolated rat heart: effects of ischemia. Magn Reson Med 2000;44:208-14 (Pubitemid 30614779)